- All
- #InspiredByLife
- Bioeconomy
- Biosimilars
- BREXIT
- Cell & Gene Therapies
- Circular Economy
- Climate Change
- COVID-19
- Factsheet
- Genome editing
- HEALTHCARE BIOTECH
- INDUSTRIAL BIOTECH
- Innovation
- Intellectual Property
- Interview
- Jobs & Growth
- NATIONAL ASSOCIATIONS
- News
- Other
- Patient Bio-Forum
- Position Paper
- Press release
- Public Procurement
- Regulatory Efficiency
- Report
- SME
- SME Platform
- WHAT IF
- White paper
June 7, 2021
May 27, 2021
2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
May 25, 2021
EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
May 20, 2021
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
May 18, 2021
EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
May 18, 2021
EuropaBio is pleased to announce that Lallemand has joined the organization as a corporate member.
May 12, 2021
EuropaBio is pleased to announce that Meatable has joined the organization as an associate member.
May 12, 2021
EuropaBio sat down with new Member Meatable, to find out about their journey from creation in 2018.
May 7, 2021
IP waiver for COVID-19 vaccines is a misguided and ineffective response to a shared global challenge
2021_05_H_PR_Waiver of Intellectual Property Rights for COVID-19 Vaccines – EuropaBio’s Position
May 4, 2021
EuropaBio sat down with new corporate member Kaffe Bueno, to find out more about the future of coffee.
